Summary
Highlights
The video introduces the topic of hypoglycemia and hyperglycemia, defining them as conditions involving imbalances in the body's glucose levels. Glucose, a simple sugar (C6H12O6), is identified as the primary energy source for the body, making its proper regulation crucial for physiological function.
Hypoglycemia is defined as a blood glucose level less than 60 mg/dL, resulting from an imbalance where glucose production is lower than its utilization. Acute hypoglycemia can be fatal if untreated due to the brain's reliance on glucose for proper function.
Causes are categorized into endogenous (tumors, metabolic errors leading to glucose overuse or insulin overproduction), exogenous (excessive insulin intake, use of secretagogues, oral anti-diabetics, certain drugs, alcohol), and functional (excessive muscle use, prolonged seizure activity, hypermetabolic states like sepsis, or dumping syndrome).
Symptoms vary by severity. Mild hypoglycemia presents with adrenergic responses like diaphoresis, tremors, tachycardia, pallor, and anxiety. Moderate to severe hypoglycemia involves central nervous system (CNS) responses such as headache, confusion, impaired judgment, slurred speech, double vision, and can progress to seizures or coma. These symptoms can mimic a stroke, necessitating a blood sugar check in such cases.
Diagnosis is confirmed by a serum blood sugar level <60 mg/dL, with levels 20-40 mg/dL potentially causing seizures and <20 mg/dL leading to coma. Prevention through patient monitoring and education is key. Initial treatment involves 10-15 grams of oral glucose (snack or gel), repeated in 10 minutes if needed, followed by complex carbohydrates. For patients unable to take oral glucose, 1-2 mg of glucagon (IV, IM, SC) or 25 grams of D50 solution via IV push are administered.
Hyperglycemia significantly increases morbidity and mortality in hospitalized patients, even those without a prior diabetes diagnosis. It's a natural metabolic response to acute illness or injury, driven by the stress response that releases glucocorticoids, catecholamines, growth hormone, and cytokines, leading to fat and protein catabolism and elevated glucose levels.
Common causes include medical conditions like MIs, strokes, surgery, trauma, pain, and sepsis, all of which trigger a stress response. Diabetes, both Type 1 (inadequate insulin production) and Type 2 (insulin receptor insensitivity), is another major cause, leading to the body's inability to uptake glucose effectively.
Management in critically ill patients focuses on frequent blood glucose monitoring and insulin management, often through continuous IV infusion. While the exact target for blood glucose is debated, a common goal is to keep levels under 180 mg/dL. The management approach also changes for conditions like Diabetic Ketoacidosis (DKA) or Hyperosmolar Hyperglycemic State (HHS), which will be discussed in detail in the next lesson.